$31.95
3.47%
Nasdaq, Sep 25, 04:17 pm EDT. Closed.
Why the stock moved Why the stock moved Beta
ISIN
US49271V1008
Symbol
KDP

Keurig Dr Pepper Inc Target price 2026 - Analyst rating & recommendation

Keurig Dr Pepper Inc Classifications & Recommendation

Buy
67%
Hold
33%

Keurig Dr Pepper Inc Price Target

Target Price $38.25
Price $31.95
Potential 19.72%
Number of Estimates 21
21 Analysts have issued a price target Keurig Dr Pepper Inc 2027 . The average Keurig Dr Pepper Inc target price is $38.25. This is 19.72% higher than the current stock price. The highest price target is $44.10 38.03% , the lowest is $29.29 8.33% .
A rating was issued by 24 analysts: 16 Analysts recommend Keurig Dr Pepper Inc to buy, 8 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Keurig Dr Pepper Inc stock has an average upside potential 2027 of 19.72% . Most analysts recommend the Keurig Dr Pepper Inc stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion $ 16.60 26.57
8.16% 60.02%
EBITDA Margin 24.47% 25.88%
0.96% 5.76%
Net Margin 12.52% 11.86%
33.40% 5.29%

22 Analysts have issued a sales forecast Keurig Dr Pepper Inc 2026 . The average Keurig Dr Pepper Inc sales estimate is

$26.6b
unlock
. This is
32.24% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$27.8b 38.22%
unlock
, the lowest is
$25.6b 27.35%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $16.6b 8.16%
2026
$26.6b 60.02%
unlock
2027
$30.3b 13.93%
unlock
2028
$31.3b 3.31%
unlock
2029
$32.7b 4.59%
unlock
2030
$33.9b 3.68%
unlock
2031
$35.1b 3.64%
unlock
2032
$36.4b 3.65%
unlock
2033
$38.1b 4.45%
unlock

18 Analysts have issued an Keurig Dr Pepper Inc EBITDA forecast 2026. The average Keurig Dr Pepper Inc EBITDA estimate is

$6.9b
unlock
. This is
69.71% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$7.5b 84.84%
unlock
, the lowest is
$6.3b 54.38%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $4.1b 9.19%
2026
$6.9b 69.21%
unlock
2027
$7.7b 12.20%
unlock
2028
$8.1b 5.55%
unlock
2029
$7.0b 13.46%
unlock
2030
$7.3b 4.03%
unlock
2031
$7.7b 4.43%
unlock
2032
$7.9b 3.59%
unlock
2033
$8.2b 3.13%
unlock

EBITDA Margin

2025 24.47% 0.96%
2026
25.88% 5.76%
unlock
2027
25.48% 1.55%
unlock
2028
26.04% 2.20%
unlock
2029
21.54% 17.28%
unlock
2030
21.62% 0.37%
unlock
2031
21.78% 0.74%
unlock
2032
21.77% 0.05%
unlock
2033
21.49% 1.29%
unlock

23 Keurig Dr Pepper Inc Analysts have issued a net profit forecast 2026. The average Keurig Dr Pepper Inc net profit estimate is

$3.2b
unlock
. This is
134.22% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$3.3b 148.58%
unlock
, the lowest is
$3.0b 123.09%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $2.1b 44.27%
2026
$3.2b 51.53%
unlock
2027
$3.5b 10.59%
unlock
2028
$3.8b 7.65%
unlock
2029
$4.0b 6.64%
unlock
2030
$4.3b 7.04%
unlock
2031
$4.6b 7.38%
unlock
2032
$4.9b 6.58%
unlock
2033
$5.2b 6.03%
unlock

Net Margin

2025 12.52% 33.40%
2026
11.86% 5.29%
unlock
2027
11.51% 2.95%
unlock
2028
11.99% 4.17%
unlock
2029
12.23% 2.00%
unlock
2030
12.62% 3.19%
unlock
2031
13.08% 3.65%
unlock
2032
13.45% 2.83%
unlock
2033
13.65% 1.49%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share $ 1.53 2.32
45.71% 51.63%
P/E 13.80
EV/Sales 2.75

23 Analysts have issued a Keurig Dr Pepper Inc forecast for earnings per share. The average Keurig Dr Pepper Inc EPS is

$2.32
unlock
. This is
134.34% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$2.46 148.48%
unlock
, the lowest is
$2.21 123.23%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $1.53 45.71%
2026
$2.32 51.63%
unlock
2027
$2.56 10.34%
unlock
2028
$2.76 7.81%
unlock
2029
$2.94 6.52%
unlock
2030
$3.15 7.14%
unlock
2031
$3.38 7.30%
unlock
2032
$3.60 6.51%
unlock
2033
$3.82 6.11%
unlock

P/E ratio

Current 32.27 34.52%
2026
13.80 57.24%
unlock
2027
12.48 9.57%
unlock
2028
11.59 7.13%
unlock
2029
10.87 6.21%
unlock
2030
10.16 6.53%
unlock
2031
9.46 6.89%
unlock
2032
8.87 6.24%
unlock
2033
8.37 5.64%
unlock

Based on analysts' sales estimates for 2026, the Keurig Dr Pepper Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.63 7.72%
2026
2.75 24.35%
unlock
2027
2.41 12.22%
unlock
2028
2.33 3.21%
unlock
2029
2.23 4.38%
unlock
2030
2.15 3.55%
unlock
2031
2.08 3.52%
unlock
2032
2.00 3.52%
unlock
2033
1.92 4.26%
unlock

P/S ratio

Current 2.16 7.39%
2026
1.64 24.38%
unlock
2027
1.44 12.23%
unlock
2028
1.39 3.20%
unlock
2029
1.33 4.39%
unlock
2030
1.28 3.56%
unlock
2031
1.24 3.52%
unlock
2032
1.19 3.52%
unlock
2033
1.14 4.26%
unlock

Current Keurig Dr Pepper Inc Upgrades & Downgrades

Analyst Rating Action Date
Argus Research
Buy
➜
Buy
Unchanged Sep 15 2026
HSBC
Hold
➜
Buy
Upgrade Aug 13 2026
Barclays
Overweight
➜
Overweight
Unchanged Aug 10 2026
Evercore ISI Group
In-Line
➜
In-Line
Unchanged Aug 07 2026
UBS
Buy
➜
Buy
Unchanged Aug 07 2026
JP Morgan
Overweight
➜
Overweight
Unchanged Jul 23 2026
UBS
Buy
➜
Buy
Unchanged Jul 16 2026
Analyst Rating Date
Unchanged
Argus Research:
Buy
➜
Buy
Sep 15 2026
Upgrade
HSBC:
Hold
➜
Buy
Aug 13 2026
Unchanged
Barclays:
Overweight
➜
Overweight
Aug 10 2026
Unchanged
Evercore ISI Group:
In-Line
➜
In-Line
Aug 07 2026
Unchanged
UBS:
Buy
➜
Buy
Aug 07 2026
Unchanged
JP Morgan:
Overweight
➜
Overweight
Jul 23 2026
Unchanged
UBS:
Buy
➜
Buy
Jul 16 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today